QINGLING MOTORS (01122) announced that the equity holders' share of the loss for the year 2025 is approximately 26.316 million yuan, a decrease of 52.24% year-on-year.
Qingling Motors (01122) announced its performance in 2025, with a total annual car sales of 33,226 units, an increase of 0.14% compared to the previous year. The revenue is approximately 4.367 billion yuan, a year-on-year growth of 5.89%; the company's equity holders' share of the loss is approximately 26.316 million yuan, a year-on-year decrease of 52.24%; the basic loss per share is 0.01 yuan.
Qingling Motors (01122) announced its performance for the year 2025, with total car sales of 33,226 units, an increase of 0.14% compared to the previous year. The revenue is approximately 4.367 billion yuan, a year-on-year increase of 5.89%; the company's equity owners' losses are estimated to be approximately 26.316 million yuan, a decrease of 52.24% compared to the previous year; the basic loss per share is 0.01 yuan.
The announcement stated that the increase in revenue is mainly due to an increase in sales.
Related Articles

Guangzhou Automobile Group (02238) plans to sell a 12% equity stake in Xinjiang Kunlun Blue Diamond Mining Development Co., Ltd. for 1.92 billion yuan.

TEDA BIOMEDICAL (08189) released its annual performance with a net loss of 90.82 million yuan attributable to shareholders, an increase of 226.67% year-on-year.

Sandmartin International (00482) releases annual financial performance, with a net loss attributable to shareholders of HK$115 million, a year-on-year increase of 274.84%.
Guangzhou Automobile Group (02238) plans to sell a 12% equity stake in Xinjiang Kunlun Blue Diamond Mining Development Co., Ltd. for 1.92 billion yuan.

TEDA BIOMEDICAL (08189) released its annual performance with a net loss of 90.82 million yuan attributable to shareholders, an increase of 226.67% year-on-year.

Sandmartin International (00482) releases annual financial performance, with a net loss attributable to shareholders of HK$115 million, a year-on-year increase of 274.84%.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


